Related references
Note: Only part of the references are listed.Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa
Bryan Vonasek et al.
AIDS (2021)
Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy
Mitch M. Matoga et al.
CLINICAL INFECTIOUS DISEASES (2021)
Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda
Rachel K. Lim et al.
PLOS ONE (2021)
Symptom-based Screening Versus Chest Radiography for TB Child Contacts: A Systematic Review and Meta-analysis
Anca Vasiliu et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
Aashna Uppal et al.
PLOS MEDICINE (2021)
Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis
Mercedes Yanes-Lane et al.
PLOS MEDICINE (2021)
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
Kelly E. Dooley et al.
LANCET HIV (2020)
Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis
Clay Roscoe et al.
BMC PUBLIC HEALTH (2020)
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis
N. Kalema et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2020)
Effect of tuberculosis infection on mortality of HIV-infected patients in Northern Tanzania
Edson W. Mollel et al.
TROPICAL MEDICINE AND HEALTH (2020)
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
S. Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa
Adrienne E. Shapiro et al.
AIDS (2018)
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review
Daniel Atwine et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV
S. Sawry et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study
S. S. Chiang et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2017)
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study
Christina Yoon et al.
LANCET INFECTIOUS DISEASES (2017)
Preventing tuberculosis in people with HIV-no more excuses
Richard E. Chaisson et al.
LANCET GLOBAL HEALTH (2017)
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
Anani Badje et al.
LANCET GLOBAL HEALTH (2017)
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Sanjeev Sinha et al.
BMC INFECTIOUS DISEASES (2017)
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection
Amy L. Sandul et al.
CLINICAL INFECTIOUS DISEASES (2017)
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study
Swe Swe Thit et al.
BMC MEDICINE (2017)
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
Timothy R. Sterling et al.
AIDS (2016)
TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis
Nathan Ford et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2016)
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Rein M. G. J. Houben et al.
PLOS MEDICINE (2016)
Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya
Surbhi Modi et al.
PLOS ONE (2016)
Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis
Taraz Samandari et al.
AIDS (2015)
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
Christine Danel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pharmacological Interactions Between Rifampicin and Antiretroviral Drugs: Challenges and Research Priorities for Resource-Limited Settings
Hadija H. Semvua et al.
THERAPEUTIC DRUG MONITORING (2015)
Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland
Rishi K. Gupta et al.
LANCET HIV (2015)
Long-term Protection From Isoniazid Preventive Therapy for Tuberculosis in HIV-Infected Patients in a Medium-Burden Tuberculosis Setting: The TB/HIV in Rio (THRio) Study
Jonathan E. Golub et al.
CLINICAL INFECTIOUS DISEASES (2015)
Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped
Faiz Ahmad Khan et al.
AIDS (2014)
Risk factors for treatment default in close contacts with latent tuberculous infection
C. T. Fiske et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
Molebogeng X. Rangaka et al.
LANCET (2014)
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253
S. Swindells et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Blood Neutrophil Counts in HIV-Infected Patients with Pulmonary Tuberculosis: Association with Sputum Mycobacterial Load
Andrew D. Kerkhoff et al.
PLOS ONE (2013)
Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?
Stephen D. Lawn et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding
Y. Hanifa et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Undiagnosed Tuberculosis Among HIV Clinic Attendees: Association With Antiretroviral Therapy and Implications for Intensified Case Finding, Isoniazid Preventive Therapy, and Infection Control
Tendesayi Kufa et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Interferon-γ Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-Analysis
Miguel Santin et al.
PLOS ONE (2012)
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
Amitabh B. Suthar et al.
PLOS MEDICINE (2012)
Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-Analysis
Adithya Cattamanchi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
Taraz Samandari et al.
LANCET (2011)
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
Neil A. Martinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies
Haileyesus Getahun et al.
PLOS MEDICINE (2011)
Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions
Haileyesus Getahun et al.
AIDS (2010)
HIV Infection-Related Tuberculosis: Clinical Manifestations and Treatment
Timothy R. Sterling et al.
CLINICAL INFECTIOUS DISEASES (2010)
A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse-Transcriptase Inhibitor-Based Regimens in HIV-Infected Patients Receiving Rifampicin: The N2R Study
Weerawat Manosuthi et al.
CLINICAL INFECTIOUS DISEASES (2009)
Detection and Prediction of Active Tuberculosis Disease by a Whole-Blood Interferon-γ Release Assay in HIV-1-Infected Individuals
Maximilian C. Aichelburg et al.
CLINICAL INFECTIOUS DISEASES (2009)
T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings
Keertan Dheda et al.
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Patient choice promotes adherence in preventive treatment for latent tuberculosis
T. W. Rennie et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection
Molebogeng Xheeda Rangaka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial
Heather J. Zar et al.
BRITISH MEDICAL JOURNAL (2007)
Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals
Annie F. Luetkemeyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Luigia Elzi et al.
CLINICAL INFECTIOUS DISEASES (2007)
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons - An international randomized trial
F Gordin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
